Demographic and clinical features of patients with and without C5a-mediated neutrophil dysfunction.
Variable . | Dysfunction . | No Dysfunction . | P . |
---|---|---|---|
No. of patients | 38 | 22 | |
Median age, y (range) | 58 (20-88) | 62 (26-80) | .9* |
Male, % | 50% | 64% | .42† |
Admitted to ICU with sepsis, % | 32% | 45% | .42† |
Surgical patients, % | 32% | 31% | 1† |
Receiving corticosteroids, % | 26% | 19% | .75† |
Comorbid conditions, median (IQR; Charlson index) | 3 (2-5) | 3 (1-4) | .52* |
Intubated, % | 92% | 91% | 1† |
With a central venous catheter, % | 82% | 77% | .74† |
APACHE II score, median (IQR) | 21 (19-29) | 22 (15-29) | .81* |
Acquiring infection in ICU, % | 53% | 9% | .0007† |
Variable . | Dysfunction . | No Dysfunction . | P . |
---|---|---|---|
No. of patients | 38 | 22 | |
Median age, y (range) | 58 (20-88) | 62 (26-80) | .9* |
Male, % | 50% | 64% | .42† |
Admitted to ICU with sepsis, % | 32% | 45% | .42† |
Surgical patients, % | 32% | 31% | 1† |
Receiving corticosteroids, % | 26% | 19% | .75† |
Comorbid conditions, median (IQR; Charlson index) | 3 (2-5) | 3 (1-4) | .52* |
Intubated, % | 92% | 91% | 1† |
With a central venous catheter, % | 82% | 77% | .74† |
APACHE II score, median (IQR) | 21 (19-29) | 22 (15-29) | .81* |
Acquiring infection in ICU, % | 53% | 9% | .0007† |